Biblio

Found 15 results
Filters: Keyword is Analgesics, Opioid  [Clear All Filters]
2023
Jones KFitzgerald, Jacob MO'Reilly, Spetz J, Hailer L, Tierney M. Eliminate the buprenorphine DEA X waiver: Justification using a policy analysis approach. J Nurs Scholarsh. 2023 ;55(3):655-664.
Cooke A, Castellanos S, Enriquez C, Olsen P, Miaskowski C, Kushel M, Knight KRay. Telehealth for management of chronic non-cancer pain and opioid use disorder in safety net primary care. BMC Health Serv Res. 2023 ;23(1):325.
2022
Nguyen T, Muench U, Andraka-Christou B, Simon K, W Bradford D, Spetz J. The Association Between Scope of Practice Regulations and Nurse Practitioner Prescribing of Buprenorphine After the 2016 Opioid Bill. Med Care Res Rev. 2022 ;79(2):290-298.
Shin SS, LaForge K, Stack E, Pope J, Leichtling G, Larsen JE, Leahy JM, Seaman A, Hoover D, Chisholm L, et al. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply. Harm Reduct J. 2022 ;19(1):76.
LaForge K, Stack E, Shin S, Pope J, Larsen JE, Leichtling G, Leahy JM, Seaman A, Hoover D, Byers M, et al. Knowledge, attitudes, and behaviors related to the fentanyl-adulterated drug supply among people who use drugs in Oregon. J Subst Abuse Treat. 2022 ;141:108849.
Obadan-Udoh E, Jura M, Wang S, Werts M, Martiniano R, Muench U, Mertz E. A longitudinal cohort study of opioid prescriptions associated with nonsurgical dental visits among Oregon and New York state Medicaid beneficiaries, 2014-2016. J Am Dent Assoc. 2022 ;153(5):460-469.
Beliveau CM, McMahan VM, Arenander J, Angst MS, Kushel M, Torres A, Santos G-M, Coffin PO. Stimulant use for self-management of pain among safety-net patients with chronic non-cancer pain. Subst Abus. 2022 ;43(1):179-186.
2021
Garrett SB, Nicosia F, Thompson N, Miaskowski C, Ritchie CS. Barriers and facilitators to older adults' use of nonpharmacologic approaches for chronic pain: a person-focused model. Pain. 2021 ;162(11):2769-2779.
Gray M, LaForge K, Livingston CJ, Leichtling G, Choo EK. Experiences of Nonpharmacologic Providers Implementing the Oregon Back Pain Policy Expanding Services for Medicaid Recipients: A Focus Group Study. J Altern Complement Med. 2021 ;27(10):868-875.
Suen LW, McMahan VM, Rowe C, Bhardwaj S, Knight K, Kushel MB, Santos G-M, Coffin P. Factors Associated with Pain Treatment Satisfaction Among Patients with Chronic Non-Cancer Pain and Substance Use. J Am Board Fam Med. 2021 ;34(6):1082-1095.
Chu CE, Law L, Zuniga K, Lin TKuo, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, et al. Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy. Urology. 2021 ;149:168-173.
Gerlach LB, Kales HC, Kim HMyra, Zhang L, Strominger J, Covinsky K, Teno J, Bynum JPW, Maust DT. Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016. J Am Geriatr Soc. 2021 ;69(6):1479-1489.
Haq N, McMahan VM, Torres A, Santos G-M, Knight K, Kushel M, Coffin PO. Race, pain, and opioids among patients with chronic pain in a safety-net health system. Drug Alcohol Depend. 2021 ;222:108671.
2020
Gibson CJ, Grasso J, Li Y, Purcell N, Tighe J, Zamora K, Nicosia F, Seal KH. An Integrated Pain Team Model: Impact on Pain-Related Outcomes and Opioid Misuse in Patients with Chronic Pain. Pain Med. 2020 ;21(9):1977-1984.
Harbaugh CM, Malani P, Solway E, Kirch M, Singer D, Englesbe MJ, Brummett CM, Waljee JF. Self-reported disposal of leftover opioids among US adults 50-80. Reg Anesth Pain Med. 2020 ;45(12):949-954.